| 1 |
Ciaramella A, Di Nardo E, Terracciano D, Conte L, Febbraio F, Cimmino A. A new biomarker panel of ultraconserved long non-coding RNAs for bladder cancer prognosis by a machine learning based methodology. BMC Bioinformatics 2023;23:569. [PMID: 36879192 DOI: 10.1186/s12859-023-05167-6] [Reference Citation Analysis]
|
| 2 |
Zhong W, Qu H, Yao B, Wang D, Qiu J. Analysis of a Long Non-coding RNA associated Signature to Predict Survival in Patients with Bladder Cancer. Cureus. [DOI: 10.7759/cureus.24818] [Reference Citation Analysis]
|
| 3 |
Huang J, He QM, Wu Q, Zhou WM, Hao C, Wang GX, Tu XH. Long non‑coding RNA 00858 knockdown alleviates bladder cancer via regulation of the miR‑3064‑5p/CTGF axis. Oncol Rep 2021;46:164. [PMID: 34132366 DOI: 10.3892/or.2021.8115] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 4 |
Jiang H, Ni J, Zheng Y, Xu Y. Knockdown of lncRNA SNHG14 alleviates LPS-induced inflammation and apoptosis of PC12 cells by regulating miR-181b-5p. Exp Ther Med 2021;21:497. [PMID: 33791006 DOI: 10.3892/etm.2021.9928] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 5 |
He H, Wu S, Ai K, Xu R, Zhong Z, Wang Y, Zhang L, Zhao X, Zhu X. LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca2+ concentration via transcription factor GATA6. Cell Oncol (Dordr) 2021;44:219-33. [PMID: 33001357 DOI: 10.1007/s13402-020-00563-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 6 |
Li L, Lv G, Wang B, Ma H. Long Noncoding RNA LINC00525 Promotes the Aggressive Phenotype of Chordoma Through Acting as a microRNA-505-3p Sponge and Consequently Raising HMGB1 Expression. Onco Targets Ther 2020;13:9015-27. [PMID: 32982292 DOI: 10.2147/OTT.S268678] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Sun X, Shen H, Liu S, Gao J, Zhang S. Long noncoding RNA SNHG14 promotes the aggressiveness of retinoblastoma by sponging microRNA‑124 and thereby upregulating STAT3. Int J Mol Med 2020;45:1685-96. [PMID: 32236565 DOI: 10.3892/ijmm.2020.4547] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 8 |
Wu D, Zhang T, Wang J, Zhou J, Pan H, Qu P. Long noncoding RNA NNT-AS1 enhances the malignant phenotype of bladder cancer by acting as a competing endogenous RNA on microRNA-496 thereby increasing HMGB1 expression. Aging (Albany NY) 2019;11:12624-40. [PMID: 31848324 DOI: 10.18632/aging.102591] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Li S, Zheng K, Pei Y, Wang W, Zhang X. Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p. Aging (Albany NY) 2019;11:11609-23. [PMID: 31801112 DOI: 10.18632/aging.102563] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 10 |
Ma B, Li Y, Ren Y. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer. Cancer Med 2020;9:335-49. [PMID: 31743579 DOI: 10.1002/cam4.2621] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
|
